About Brutec Pharma Private Limited
Data last updated:
Brutec Pharma Private Limited is a private limited company based in Thodupuzha, Kerala, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 11 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U36999KL2018PTC051695. Its GSTIN is 32AAHCB6092M1ZE (Kerala).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Ramees Riyas (Managing Director) and Bhaskaran Gopal Vinodh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Brutec Pharma Thodupuzha East P.O. Mangattukavala Near Josh Travels, Kerala, India – 685585.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.83 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.32 Cr (net margin 25.9%) and EBITDA of ₹10.47 Cr (EBITDA margin 26.3%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years and 96% over five years.
As per MCA filings, the company has open charges of ₹4.95 Cr and satisfied charges of ₹12 Lakh on record.
For more details, the company can be reached via its website brutecpharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBrutec Pharma Thodupuzha East P.O. Mangattukavala Near Josh Travels, Kerala, India – 685585
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Brutec Pharma Private Limited
The main business activity of Brutec Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Brutec Pharma Private Limited FY 2024 filings available
Brutec Pharma Private Limited reported revenue of ₹39.83 Cr (up 301% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Brutec Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 96% over five years, including 301% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Brutec Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.47 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.32 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Brutec Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 25.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Brutec Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Brutec Pharma Private Limited
Brutec Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskaran Gopal Vinodh Also directs: Nutraguard Healthcare Private Limited | Whole-Time Director | 01 Dec 2024 | 1 Years 10 Months | Current |
| Ramees Riyas Also directs: Nutraguard Healthcare Private Limited, Crunch Wave Private Limited | Managing Director | 15 Jul 2019 | 7 Years 3 Months | Current |
| Rayees Riyas Also directs: Crunch Wave Private Limited | Additional Director | 11 Nov 2024 | 1 Years 11 Months | Current |
| Aboobaker Puthuparambil Ismail Also directs: Nutraguard Healthcare Private Limited | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
Peer Comparison of Brutec Pharma Private Limited
Brutec Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Patanjali Distributors Private Limited | ₹47.97 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Sr Institute of Advanced Ayurvedic Sciences Private Limited | ₹47.61 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Haryana, India |
| Source Natural Foods and Herbal Supplements Limited Listed | ₹45 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Bangalore, Karnataka, India |
| Sunrise Remedies Private Limited | ₹40.84 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Lepro Herbals Private Limited | ₹40.25 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | New Delhi, Delhi, India |
| Brutec Pharma Private Limited this company | ₹39.83 Cr (FY 2025) | •••• | •••• | 301.0% | •••• | Thodupuzha, Kerala, India |
| Rex Remedies Limited | ₹39.37 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Delhi, India |
| Ytm India Marketing Private Limited | ₹39.24 Cr (FY 2025) | •••• | •••• | •••• | Raipur, Chhattisgarh, India | |
| Sanskar Ayush Medicare Private Limited | ₹38.99 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Haridwar, Uttarakhand, India |
| Skyline Herbals Private Limited | ₹38.76 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| A R Ayurveda Private Limited | ₹38.34 Cr (FY 2025) | •••• | •••• | 162.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Brutec Pharma by revenue in the Healthcare industry (Ayurvedic Products and Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Brutec Pharma Private Limited
Brutec Pharma Private Limited is audited by Arpana & Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Arpana & Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Brutec Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Brutec Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2025 | Others | ₹4.95 Cr | Open |
| 04 Nov 2019 | The South Indian Bank Limited | ₹12 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Brutec Pharma Private Limited
Employment history and EPFO contributions of people linked to Brutec Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Brutec Pharma Private Limited
Brutec Pharma Private Limited has 8 board changes on record since 2018: 4 appointments and 4 cessations. The latest: Bhaskaran Gopal Vinodh was appointed as Whole-Time Director on 01 Dec 2024.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Brutec Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Brutec Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Brutec Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Brutec Pharma Private Limited
Brutec Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCB6092M1ZE | Kerala | Active | 20 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Brutec Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brutec Pharma Private Limited
Brutec Pharma is an active private limited company based in Thodupuzha, Kerala, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 11 January 2018 (8+ years old) and is registered under CIN U36999KL2018PTC051695.
Brutec Pharma reported revenue of ₹39.83 Cr for FY 2025 (up 301% YoY).
Brutec Pharma has 4 current directors:
- Ramees Riyas - Managing Director
- Bhaskaran Gopal Vinodh - Whole-Time Director
- Rayees Riyas - Additional Director
- Aboobaker Puthuparambil Ismail - Director
Brutec Pharma reported a net profit of ₹10.32 Cr (net margin 25.9%) and EBITDA of ₹10.47 Cr (EBITDA margin 26.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Brutec Pharma is 96% over three years and 96% over five years. In the latest year (FY 2025) revenue rose 301%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Brutec Pharma is 32AAHCB6092M1ZE, registered in Kerala.
The CIN (Corporate Identification Number) of Brutec Pharma is U36999KL2018PTC051695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brutec Pharma was incorporated on 11 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Brutec Pharma by revenue are Patanjali Distributors Private Limited, Sr Institute of Advanced Ayurvedic Sciences Private Limited, Source Natural Foods and Herbal Supplements Limited, Sunrise Remedies Private Limited, Lepro Herbals Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services).
Bhaskaran Gopal Vinodh was appointed as Whole-Time Director on 01 Dec 2024. Bhaskaran Gopal Vinodh ceased to be Additional Director on 01 Dec 2024. Rayees Riyas was appointed as Additional Director on 11 Nov 2024. Brutec Pharma has 8 board changes on record in total.
Brutec Pharma can be reached through the website brutecpharma.com. Its registered office is in Thodupuzha, Kerala, India.